Prefilled Syringes Market

Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) - Global Forecast to 2025

Report Code: MD 4755 Sep, 2020, by marketsandmarkets.com

[149 Pages Report] The global prefilled syringes market size is projected to reach USD 8.6 billion by 2025 from USD 5.6 billion in 2020, at a CAGR of 9.0% during the forecast period. growth in the prefilled syringes market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the growth of the prefilled syringes market.

Prefilled Syringes Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global prefilled syringes market

The prefilled syringes market is impacted due to the pandemic, resulting in impact of the pandemic on drug manufacturing and supply chain is expected to affect the market for the short term. Furthermore, HCPs have adapted to new ways of delivering care using telemedicine to reduce face-to-face contact, and adopting new ways of virtual healthcare and digital technologies is imperative to allow HCPs to continue routine appointments. Further, the use of apps can support self-management of chronic conditions, i.e., continuous glucose monitoring enables support with diabetes. Similarly, the contribution of community pharmacists to manage chronic conditions and promote medication adherence during this COVID-19 pandemic will be essential in easing the burden on already strained health systems.

Prefilled Syringes Market Dynamics

Driver: Rising target disease population

Prefilled syringes are mainly used for the treatment of chronic conditions, such as heart diseases, diabetes, and autoimmune diseases, which require patients to self-administer medications. As a result, the increasing incidence and prevalence of chronic and lifestyle diseases across the globe is a major factor contributing to the growth of the prefilled syringes market. Moreover, there is a growing demand for self-injection devices, considering the convenience and safety associated with their use.

Following are some of the key statistics related to the growing incidence and prevalence of chronic diseases:

  •  Globally, in 2019, approximately 436 million adults (prevalence 9.3%) were suffering from diabetes, and it is expected to rise to 700 million (prevalence 10.9%) by 2045. Moreover, more than 1.1 million children and adolescents are living with type 1 diabetes (Source: International Diabetes Federation)
  •  In 2018, total number of cancer cases globally was recorded at 18 million. Most common cases being lung, breast, and colorectum cancer with incidence rate in double digits (Source: WHO)
  •  According to the National Institute of Environmental Health Science, in 2017, 24 million people had a condition of autoimmune disease in the US. Moreover, 8 million people had auto-antibodies—blood molecules that indicate a person's chance of developing autoimmune disease

Restraint: Dearth of prefilled syringes with integrated safety features

Prefilled syringes provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medication from vials. However, a significant number of needle stick injuries are associated with the use of bare prefilled syringes as compared to the ones that have integrated safety systems. As of 2019, ~500,000 injuries occur in the US annually, in which half of those (nearly 1,000 per day) occur in hospitals. Furthermore, as of 2019, ~1,000,000 injuries occurred annually in Europe. In such cases, the contaminated needle of prefilled syringes can lead to blood-borne infections, such as HIV and HCV.

Considering this, the limited market presence of prefilled syringes with integrated safety features, due to their expensive and challenging manufacturing procedure, is a major concern in the market. However, this trend is expected to change in the coming years, as the healthcare industry is laying greater emphasis on reducing the rate of needlestick injuries, which, in turn, is paving the way for the development of safety prefilled syringes.  

Opportunity: Growing  healthcare infrastructure across emerging markets

Emerging countries continue to suffer from insufficient healthcare funding, which adversely affects access to healthcare, quality, and, ultimately, the health status of citizens. According to the World Bank, approximately 400 million people lack access to essential healthcare services, mostly in Africa and South Asia. Furthermore, accelerating medical inflation, i.e., the cost of medical treatments and a higher prevalence of non-communicable lifestyle-related diseases such as cancer, diabetes, or cardiac syndromes, have resulted in funding gaps.

According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum, which is driven by the accelerating cost of medical treatment, expanding treatment options and increasing customer demands. Moreover, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will almost triple to USD 24 trillion by 2040 with upper-middle-income countries are estimated to show the fastest increase at an average of 5.3% per year. This growth could be attributed to continued growth in GDP and the rise of the middle class and government spending.

Challenge: Availibility of cheaper alternatives

The purchase cost of prefilled syringes as compared to disposable syringes is significantly higher as a result of the high expenses involved in their manufacturing.

Traditionally, injectable were invasive and painful, which was the major reason for patients to prefer alternate routes of drug delivery, such as oral, topical, and nasal. Among the various routes of drug delivery, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Due to the abovementioned factors, the adoption of alternative drug delivery technologies is increasing across the globe. For instance, the development of alternate, cost-effective delivery methods for insulin, such as Pfizer's Exubera (inhalable insulin) and Medtronic's Veo insulin pump (inhalable insulin), is limiting the use of injectable insulin. Currently, insulin is mostly administered through injections, and thus, insulin injections form a significant market for injectable drug delivery technologies. However, the advent of inhalable insulin is expected to significantly impact the growth of this market as nasal drug delivery is pain-free and highly patient compliant. Also, the development of alternate delivery techniques for other disease indications, such as oral anemia treatment by GlaxoSmithKline and Bayer, is expected to adversely affect the growth of injectable technologies in the coming years.

By type, the safety prefilled syringes segment is expected to grow at the highest CAGR during the forecast period

The safety prefilled syringes segment is expected to witness the highest growth during the forecast period primarily due to the rising geriatric population globally and availability of biological therapies for patients with chronic conditions and outsourcing of low-risk medical procedures for chronic patients alleviates some of the pressure on hospitals

Glass prefilled syringes is the largest material segment of the prefilled syringes market

The glass prefilled syringes segment accounted for the largest share of the prefilled syringes industry in 2019. The large share of this segment is attributed to the significant benefits offered, such as prevention of oxygen and water vapor from interacting with drug compounds, compatibility with different filling machines, and seamless integration into pharmaceutical companies’ PFS operations.

Single-chamber prefilled syringes accounted for the largest share of the prefilled syringes market, by design, in 2019

The single-chamber prefilled syringes segment accounted for the largest share of the prefilled syringes industry in 2019. Market growth can largely be attributed to the significant advantages with the use of single-chamber prefilled syringes over vials, such as optimized API use with less overfill, reduced material requirements, less drug waste in clinical trials, and simple storage & disposal. Additionally, increasing adoption of self-administered parenteral drugs due to the increasing prevalence of chronic diseases and benefits offered by prefilled syringes

Prefilled Syringes Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Europe is the largest regional market for prefilled syringes

Europe is one of the major revenue-generating regions in the prefilled syringes market. Rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes.  are the major factors driving the growth of the prefilled syringes market in Europe.

Key Market Players

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Becton, Dickinson and Company (US) held the leadership position in the global prefilled syringes market with a share of 37.2% in 2019. The company’s dominant position in this market can be attributed to its broad product portfolio of prefilled syringes, strong geographical presence, and wide customer base. The company primarily focuses on the strategy of product launch.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2018–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD)

Segments Covered

Type, Material, Design, Application, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA

Companies Covered

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan)

This research report categorizes the prefilled syringes market based on type, material, design, application, and region.

By Type

  • Conventional Prefilled Syringes
    • Disposable Prefilled Syringes
    • Reusable Prefilled Syringes
  • Safety Prefilled Syringes

By Material

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

By Design

  • Single-Chamber Prefilled Syringes
  • Dual- Chamber Prefilled Syringes
  • Customized Prefilled Syringes

By Application

  • Diabetes
  • Rheumatoid Arthritis
  • Anaphylaxis
  • Cancer
  • Thrombosis
  • Ophthalmology
  • Others

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
    • Middle East and Africa

Recent Developments

  • In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.
  • In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)
  • In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 21)
    1.1 OBJECTIVES OF THE STUDY
    1.2 PRODUCT DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY USED FOR THE STUDY
    1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 24)
    2.1 RESEARCH DATA
        FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                 FIGURE 2 BREAKDOWN OF PRIMARIES: PREFILLED SYRINGES AND SUPPORTS MARKET
    2.2 MARKET ESTIMATION METHODOLOGY
        FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 END USER-BASED MARKET ESTIMATION
           2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
                 FIGURE 4 MARKET SIZE ESTIMATION: PREFILLED SYRINGES MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
        FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 32)
  FIGURE 6 GLOBAL PREFILLED SYRINGES MARKET, BY MATERIAL, 2020 VS. 2025 (IN TERMS OF % MARKET SHARE)
  FIGURE 7 GLOBAL PREFILLED SYRINGES MARKET, BY TYPE, 2016 VS. 2021 (USD BILLION)
  FIGURE 8 GLOBAL PREFILLED SYRINGES MARKET, BY DESIGN, 2020 VS. 2025 (USD BILLION)
  FIGURE 9 GLOBAL PREFILLED SYRINGES MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
  FIGURE 10 EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PREFILLED SYRINGES MARKET

4 PREMIUM INSIGHTS (Page No. - 36)
    4.1 PREFILLED SYRINGES MARKET OVERVIEW
        FIGURE 11 RISING PREVALENCE OF AUTOIMMUNE DISORDERS IS DRIVING THE MARKET GROWTH
    4.2 PREFILLED SYRINGES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
        FIGURE 12 REUSABLE PREFILLED SYRINGES SEGMENT IS EXPECTED TO DOMINATE THE MARKET BY 2025
    4.3 GEOGRAPHIC ANALYSIS: PREFILLED SYRINGES MARKET, BY MATERIAL
        FIGURE 13 ASIA PACIFIC SEGMENT TO POSSESS HIGH GROWTH RATE DURING THE FORECAST PERIOD
    4.4 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY DESIGN AND COUNTRY (2020)
        FIGURE 14 SINGLE-CHAMBER PREFILLED SYRINGES SEGMENT IS EXPECTED TO DOMINATE THE ASIA PACIFIC MARKET
    4.5 PREFILLED SYRINGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 39)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 16 PREFILLED SYRINGES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising target disease population
                    5.2.1.2 Rapid growth in generic products
                    5.2.1.3 Rising adoption of self-medication and digitalization
                    5.2.1.4 Affordable cost with increased efficiency of prefilled syringes
                    5.2.1.5 Technological advancements
           5.2.2 RESTRAINTS
                    5.2.2.1 Dearth of prefilled syringes with integrated safety features
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare infrastructure across emerging markets
                    5.2.3.2 Surge of biologics and biosimilars in biopharma industry
                    5.2.3.3 Increasing adoption of wearable drug delivery technologies
           5.2.4 CHALLENGES
                    5.2.4.1 Availability of cheaper alternatives
                    5.2.4.2 Challenges associated with manufacturing of prefilled syringes
           5.2.5 REGULATORY SCENARIO
           5.2.6 COVID-19 IMPACT

6 PREFILLED SYRINGES MARKET, BY TYPE (Page No. - 47)
    6.1 INTRODUCTION
        TABLE 1 PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 2 PREFILLED SYRINGES MARKET, BY TYPE, 2019 (MILLION UNITS)
    6.2 CONVENTIONAL PREFILLED SYRINGES
        TABLE 3 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 4 CONVENTIONAL PREFILLED SYRINGES MARKET, BY TYPE, 2019 (MILLION UNITS)
        TABLE 5 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
        TABLE 6 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
        TABLE 7 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
        TABLE 8 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
        TABLE 9 GLOBAL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           6.2.1 DISPOSABLE PREFILLED SYRINGES
                 TABLE 10 GLOBAL DISPOSABLE PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
                 TABLE 11 GLOBAL DISPOSABLE PREFILLED SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
                 TABLE 12 GLOBAL DISPOSABLE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
                 TABLE 13 GLOBAL DISPOSABLE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
                 TABLE 14 GLOBAL DISPOSABLE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
           6.2.2 REUSABLE PREFILLED SYRINGES
                 TABLE 15 GLOBAL REUSABLE PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
                 TABLE 16 GLOBAL REUSABLE PREFILLED SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
                 TABLE 17 GLOBAL REUSABLE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
                 TABLE 18 GLOBAL REUSABLE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
                 TABLE 19 GLOBAL REUSABLE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    6.3 SAFETY PREFILLED SYRINGES
        TABLE 20 GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
        TABLE 21 GLOBAL SAFETY PREFILLED SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
        TABLE 22 GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
        TABLE 23 GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
        TABLE 24 GLOBAL SAFETY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)

7 PREFILLED SYRINGES MARKET, BY MATERIAL (Page No. - 58)
    7.1 INTRODUCTION
        TABLE 25 GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
    7.2 GLASS PREFILLED SYRINGES
        TABLE 26 GLOBAL GLASS PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
    7.3 PLASTIC PREFILLED SYRINGES
        TABLE 27 GLOBAL PLASTIC PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)

8 PREFILLED SYRINGES MARKET, BY DESIGN (Page No. - 62)
    8.1 INTRODUCTION
        TABLE 28 PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
    8.2 SINGLE-CHAMBER PREFILLED SYRINGES
        TABLE 29 SINGLE-CHAMBER PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
    8.3 DUAL-CHAMBER PREFILLED SYRINGES
        TABLE 30 GLOBAL DUAL-CHAMBER PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
    8.4 CUSTOMIZED PREFILLED SYRINGES
        TABLE 31 GLOBAL CUSTOMIZED PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)

9 PREFILLED SYRINGES MARKET, BY APPLICATION (Page No. - 66)
    9.1 INTRODUCTION
        TABLE 32 PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
    9.2 DIABETES
        TABLE 33 GLOBAL PREFILLED SYRINGES MARKET FOR DIABETES, BY REGION, 2018–2025 (USD MILLION)
    9.3 RHEUMATOID ARTHRITIS
        TABLE 34 GLOBAL PREFILLED SYRINGES MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018–2025 (USD MILLION)
    9.4 ANAPHYLAXIS
        TABLE 35 GLOBAL PREFILLED SYRINGES MARKET FOR ANAPHYLAXIS, BY REGION, 2018–2025 (USD MILLION)
    9.5 CANCER
        TABLE 36 GLOBAL PREFILLED SYRINGES MARKET FOR CANCER, BY REGION, 2018–2025 (USD MILLION)
    9.6 THROMBOSIS
        TABLE 37 GLOBAL PREFILLED SYRINGES MARKET FOR THROMBOSIS, BY REGION, 2018–2025 (USD MILLION)
    9.7 OPHTHALMOLOGY
        TABLE 38 GLOBAL PREFILLED SYRINGES MARKET FOR OPHTHALMOLOGY, BY REGION, 2018–2025 (USD MILLION)
    9.8 OTHERS
        TABLE 39 GLOBAL PREFILLED SYRINGES MARKET FOR OTHERS, BY REGION, 2018–2025 (USD MILLION)

10 PREFILLED SYRINGES MARKET, BY REGION (Page No. - 73)
     10.1 INTRODUCTION
          TABLE 40 GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION)
          TABLE 41 PREFILLED SYRINGES MARKET, BY REGION, 2019 (MILLION UNITS)
     10.2 NORTH AMERICA
          TABLE 42 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 43 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
          TABLE 44 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
          TABLE 45 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 46 NORTH AMERICA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 47 NORTH AMERICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate the market in North America
                                 TABLE 48 US PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 49 US CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Rising geriatric population to drive market growth
                                 TABLE 50 CANADA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 51 CANADA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
     10.3 EUROPE
          TABLE 52 EUROPE PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 53 EUROPE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
          TABLE 54 EUROPE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
          TABLE 55 EUROPE PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 56 EUROPE CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 57 EUROPE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany to dominate the market in Europe
                                 TABLE 58 GERMANY PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 59 GERMANY CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Growing number of CVD and diabetes patients to drive market growth
                                 TABLE 60 UK PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 61 UK CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing needlestick injuries and high adoption of self-administration to drive market growth
                                 TABLE 62 FRANCE PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 63 FRANCE CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Growing focus of pharmaceutical and medical device companies on development of prefilled syringes to aid market growth
                                 TABLE 64 ITALY PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 65 ITALY CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 High cancer and diabetes prevalence to drive the market
                                 TABLE 66 SPAIN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 67 SPAIN CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.3.6 REST OF EUROPE (ROE)
                    TABLE 68 ROE PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 69 ROE CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
          TABLE 70 ASIA PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 71 ASIA PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
          TABLE 72 ASIA PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
          TABLE 73 ASIA PACIFIC PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 74 ASIA PACIFIC CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 75 ASIA PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
             10.4.1 CHINA
                        10.4.1.1 Growing R&D activities and localized manufacturing are expected to drive market growth
                                 TABLE 76 CHINA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 77 CHINA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.4.2 INDIA
                        10.4.2.1 Growing cancer rate and heart diseases to drive the market
                                 TABLE 78 INDIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 79 INDIA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Growing demand for self-injection technologies to drive the market
                                 TABLE 80 JAPAN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 81 JAPAN CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.4.4 SOUTH KOREA
                        10.4.4.1 Rising R&D activities focused on prefilled syringes are driving the market
                                 TABLE 82 SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 83 SOUTH KOREA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.4.5 AUSTRALIA
                        10.4.5.1 Growing healthcare expenditure and infrastructure to aid market growth
                                 TABLE 84 AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 85 AUSTRALIA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                    TABLE 86 ROAPAC PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 87 ROAPAC CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
     10.5 LATIN AMERICA
          TABLE 88 LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 89 LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
          TABLE 90 LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
          TABLE 91 LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 92 LATIN AMERICA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 93 LATIN AMERICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Brazil accounted for the largest share of the Latin American market
                                 TABLE 94 BRAZIL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 95 BRAZIL CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Growing drug delivery market to support growth
                                 TABLE 96 MEXICO PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE 97 MEXICO CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA (ROLA)
                    TABLE 98 ROLA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE 99 ROLA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
          TABLE 100 MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL, 2018–2025 (USD MILLION)
          TABLE 101 MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018–2025 (USD MILLION)
          TABLE 102 MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 103 MIDDLE EAST & AFRICA CONVENTIONAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 104 MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 103)
     11.1 OVERVIEW
          FIGURE 17 KEY DEVELOPMENTS IN THE PREFILLED SYRINGES MARKET FROM 2017 TO 2020
     11.2 GLOBAL MARKET SHARE ANALYSIS (2019)
          FIGURE 18 BECTON, DICKINSON AND COMPANY HELD THE LEADING POSITION IN THE PREFILLED SYRINGES MARKET IN 2019
     11.3 COMPETITIVE SCENARIO (2017 – 2020)
          FIGURE 19 MAJOR COMPANIES FOCUSES ON MARKET EXPANSIONS TO MAINTAIN ITS HIGH MARKET SHARE AND TO BUILD ITS COMPETITIVE ADVANTAGE
             11.3.1 KEY PRODUCT LAUNCHES (2017-20120)
             11.3.2 KEY EXPANSIONS (2017-2020)
             11.3.3 KEY MERGERS AND ACQUISITIONS (2017-2020)
             11.3.4 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2020)

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 108)
     12.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
             12.1.1 VENDOR INCLUSION CRITERIA
                        12.1.1.1 Star
                        12.1.1.2 Emerging Leader
                        12.1.1.3 Pervasive
                        12.1.1.4 Emerging companies
                                 FIGURE 20 PREFILLED SYRINGES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
     12.2 COMPANY PROFILES
             12.2.1 GERRESHEIMER AG
                    FIGURE 21 COMPANY SNAPSHOT: GERRESHEIMER AG
             12.2.2 SCHOTT AG
                    FIGURE 22 COMPANY SNAPSHOT: SCHOTT AG
             12.2.3 BECTON, DICKINSON AND COMPANY
                    FIGURE 23 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
             12.2.4 WEST PHARMACEUTICAL SERVICES, INC.
                    FIGURE 24 COMPANY SNAPSHOT: WEST PHARMACEUTICAL SERVICES, INC.
             12.2.5 VETTER PHARMA INTERNATIONAL GMBH
             12.2.6 WEIGAO GROUP
                    FIGURE 25 COMPANY SNAPSHOT: WEIGAO GROUP
             12.2.7 OMPI (A STEVANATO GROUP COMPANY)
             12.2.8 CATALENT, INC.
                    FIGURE 26 COMPANY SNAPSHOT: CATALENT, INC.
             12.2.9 NIPRO CORPORATION
                    FIGURE 27 COMPANY SNAPSHOT: NIPRO CORPORATION
             12.2.10 BAXTER INTERNATIONAL INC.
                     FIGURE 28 COMPANY SNAPSHOT: BAXTER INTERNATIONAL, INC.
             12.2.11 ELCAM MEDICAL
             12.2.12 YPSOMED
                     FIGURE 29 COMPANY SNAPSHOT: YPSOMED
             12.2.13 OVAL MEDICAL TECHNOLOGIES LTD.
             12.2.14 SHL MEDICAL AG
             12.2.15 TERUMO CORPORATION
                     FIGURE 30 COMPANY SNAPSHOT: TERUMO CORPORATION
             12.2.16 OTHER COMPANIES
                        12.2.16.1 Haselmeier
                        12.2.16.2 Micsafe
                        12.2.16.3 Dδtwyler Holding Inc.
                        12.2.16.4 Owen Mumford Ltd
                        12.2.16.5 MedXL Inc.

13 APPENDIX (Page No. - 142)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

The study involved four major activities to estimate the current size of the prefilled syringes market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the orthopedic braces and supports market study.

Primary Research

The prefilled syringes market comprises several stakeholders such as research & academic institutions, technicians & general physicians, nurses, pharmacists, e-commerce government agencies, and research organizations. The demand side of this market is characterized by the increasing rising target disease population and increasing geriatric population globally. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

Prefilled Syringes Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the prefilled syringes market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Prefilled Syringes Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the prefilled syringes market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the orthopedic braces and supports industry.

Report Objectives

  • To define, describe, and forecast the prefilled syringes market by type, material, design, application, and region
  • To provide detailed information about major factors influencing market growth (key drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and their contributions to the overall prefilled syringes market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the market value of various segments and subsegments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players active in the prefilled syringes market and comprehensively analyze their global revenue shares and core competencies2
  • To track and analyze competitive market-specific developments such as product approvals & commercialization, agreements, partnerships, collaborations, acquisitions, and expansions in the prefilled syringes market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the prefilled syringes market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players

Product Analysis

  • Further breakdown of the Rest of Europe prefilled syringes market into Russia, Portugal, Belgium, Denmark, and Switzerland, and other European countries (aggregated)

Company Information

  • Detailed analysis and profiling of additional market players (up to 5 OEMs)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Prefilled Syringes Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Prefilled Syringes Market

Request For Special Pricing
Report Code
MD 4755
Published ON
Sep, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Prefilled Syringes Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home